These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19391223)

  • 1. ACP Journal Club. Review: Oral drugs for gestational diabetes do not increase adverse maternal and neonatal outcomes more than insulin.
    Feig D
    Ann Intern Med; 2009 Apr; 150(8):JC4-9. PubMed ID: 19391223
    [No Abstract]   [Full Text] [Related]  

  • 2. ACP Journal Club. Treatment of mild gestational diabetes did not prevent neonatal complications but reduced fetal overgrowth.
    Feig D
    Ann Intern Med; 2010 Jan; 152(2):JC1-6. PubMed ID: 20083821
    [No Abstract]   [Full Text] [Related]  

  • 3. ACP Journal Club. Review: Metformin reduces risk for CV mortality compared with other oral diabetes drugs or placebo in type 2 diabetes.
    Lipscombe L
    Ann Intern Med; 2009 Apr; 150(8):JC4-8. PubMed ID: 19391221
    [No Abstract]   [Full Text] [Related]  

  • 4. ACP Journal Club: review: dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes.
    Chatterjee S; Chatterjee S
    Ann Intern Med; 2013 Apr; 158(8):JC8. PubMed ID: 23588773
    [No Abstract]   [Full Text] [Related]  

  • 5. ACP Journal Club. Review: angiotensin-receptor blockers do not increase adverse cardiovascular outcomes.
    Halim SA; Newby LK
    Ann Intern Med; 2011 Aug; 155(4):JC2-2. PubMed ID: 21844535
    [No Abstract]   [Full Text] [Related]  

  • 6. ACP Journal Club. Review: oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints.
    Domecq JP; Prutsky G; Montori VM
    Ann Intern Med; 2011 Aug; 155(4):JC2-4. PubMed ID: 21844537
    [No Abstract]   [Full Text] [Related]  

  • 7. ACP Journal Club. Review: oral phosphodiesterase 4 inhibitors reduce exacerbations but increase adverse events in COPD.
    Ram FS
    Ann Intern Med; 2011 Sep; 155(6):JC3-2. PubMed ID: 21930839
    [No Abstract]   [Full Text] [Related]  

  • 8. Maternal and perinatal outcomes in women with gestational diabetes mellitus as compared to nondiabetic controls.
    Sendag F; Terek MC; Itil IM; Oztekin K; Bilgin O
    J Reprod Med; 2001 Dec; 46(12):1057-62. PubMed ID: 11789086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACP Journal Club. Review: Erythropoiesis-stimulating agents targeted to higher hemoglobin levels increase risk for adverse outcomes in CKD.
    Hsu CY
    Ann Intern Med; 2010 Nov; 153(10):JC5-3. PubMed ID: 21079210
    [No Abstract]   [Full Text] [Related]  

  • 10. ACP Journal Club. Review: Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomes.
    Melnikow J
    Ann Intern Med; 2010 Mar; 152(6):JC3-4. PubMed ID: 20231558
    [No Abstract]   [Full Text] [Related]  

  • 11. ACP Journal Club. Severe hypoglycemia was associated with increased risk for adverse clinical outcomes in type 2 diabetes.
    Grubina R; Smith SA
    Ann Intern Med; 2011 Feb; 154(4):JC2-13. PubMed ID: 21320928
    [No Abstract]   [Full Text] [Related]  

  • 12. The Toronto Tri-Hospital Gestational Diabetes Project. A preliminary review.
    Sermer M; Naylor CD; Farine D; Kenshole AB; Ritchie JW; Gare DJ; Cohen HR; McArthur K; Holzapfel S; Biringer A
    Diabetes Care; 1998 Aug; 21 Suppl 2():B33-42. PubMed ID: 9704225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACP Journal Club. Review: intensive glucose control reduces surrogate, but not clinical, renal outcomes in type 2 diabetes.
    Corbett EC
    Ann Intern Med; 2012 Nov; 157(10):JC5-6. PubMed ID: 23165682
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulins and oral hypoglycemic agents in pregnancy.
    Homko CJ; Reece EA
    J Matern Fetal Neonatal Med; 2006 Nov; 19(11):679-86. PubMed ID: 17127490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACP Journal Club: treatment for gestational diabetes reduces risk for shoulder dystocia.
    Horvath K
    Ann Intern Med; 2010 Sep; 153(6):JC3-6. PubMed ID: 20855795
    [No Abstract]   [Full Text] [Related]  

  • 16. Treating the mother--protecting the unborn: the safety of hypoglycemic drugs in pregnancy.
    Klieger C; Pollex E; Koren G
    J Matern Fetal Neonatal Med; 2008 Mar; 21(3):191-6. PubMed ID: 18297574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACP Journal Club: review: varenicline for tobacco cessation does not increase CV serious adverse events.
    Krebs P; Sherman SE
    Ann Intern Med; 2012 Aug; 157(4):JC2-2. PubMed ID: 22910956
    [No Abstract]   [Full Text] [Related]  

  • 18. ACP Journal Club. Review: rosiglitazone increases risk for cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetes.
    Deedwania P
    Ann Intern Med; 2011 Aug; 155(4):JC2-12. PubMed ID: 21844545
    [No Abstract]   [Full Text] [Related]  

  • 19. ACP Journal Club. Review: ACE-Is or ARBs reduce adverse CV outcomes regardless of baseline systolic blood pressure.
    Singh V
    Ann Intern Med; 2012 Jul; 157(2):JC2-8. PubMed ID: 22801699
    [No Abstract]   [Full Text] [Related]  

  • 20. Metformin for gestational diabetes in routine clinical practice.
    Goh JE; Sadler L; Rowan J
    Diabet Med; 2011 Sep; 28(9):1082-7. PubMed ID: 21679232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.